DOT1L and head and neck cancer: Taken together, these recently discovered matrix hyaluronan (HA)/CD44v3-mediated signaling pathways and DOT1L-specific epigenetic regulation in head and neck CSCs could provide unique molecular targets and specific therapeutic drugs for the treatment of head and neck cancer.